Clinical Trials in Michigan

Showing 14661-14680 of 16,154 trials

Therapy Optimization in Multiple Sclerosis (MS)

NCT00819000

The purpose of this study is to determine if higher compliance and adherence rates to drug therapy for MS result in better health outcomes than lower rates of therapy compliance and adherence.

Multiple Sclerosis

Teva Neuroscience, Inc.2,878 participantsStarted Dec 2008

Swartz Creek, Michigan, United States • Columbus, Ohio, United States • Carnegie, Pennsylvania, United States

COMPLETEDPhase 353 miles

Open Label Continuation Study in Moderate to Severe Psoriasis

NCT00626002

The purpose of this study is to evaluate long term safety, efficacy and tolerability of ABT-874 in adults with moderate to severe psoriasis.

Moderate to Severe Plaque Psoriasis

AbbVie (prior sponsor, Abbott)2,301 participantsStarted Feb 2008

Birmingham, Alabama, United States • Birmingham, Alabama, United States • Huntsville, Alabama, United States +149 more locations

Therapy Optimization in Multiple Sclerosis (MS)

Open Label Continuation Study in Moderate to Severe Psoriasis

Find Trials by Condition in Michigan

S0012 Doxorubicin, Cyclophosphamide, and Paclitaxel With or Without Filgrastim in Treating Women With Inflammatory or Locally Advanced Breast Cancer

S0121, Neoadjuvant Carboplatin, Paclitaxel, and Gemcitabine Followed by Cisplatin and Radiation Therapy in Treating Patients With Locally Advanced or Recurrent Carcinoma of the Urothelium

S0102: Docetaxel, Vinorelbine, and Filgrastim in Treating Women With Stage IV Breast Cancer

S9911, Combination Chemotherapy Plus Monoclonal Antibody Therapy in Treating Patients With Non-Hodgkin's Lymphoma

Trial of Linaclotide in Patients With Chronic Constipation

Optimize RV Selective Site Pacing Clinical Trial

A Phase 1/2 Study Evaluating ABT-751 in Combination With Alimta in Advanced Non-Small Cell Lung Cancer

Evaluation of AVE5026 in the Prevention of Venous Thromboembolism in Cancer Patients Undergoing Chemotherapy

A Phase 3 Study of Siltuximab or Placebo in Combination With Velcade and Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma

Efficacy, Safety and Pharmacokinetics of Gammaplex in Primary Immunodeficiency Diseases.

Study Evaluating SKI-606 (Bosutinib) In Subjects With Breast Cancer

FREEDOM DR: Oral Treprostinil in Combination With an Endothelin Receptor Antagonist (ERA) and/or a Phosphodiesterase-5 (PDE-5) Inhibitor or as Monotherapy for the Treatment of Pulmonary Arterial Hypertension (PAH)

The Prediction of Extent and Risk Profile of Coronary Atherosclerosis and Their Changes During Lipid-lowering Therapy Based on Non-invasive Techniques

Safety and Efficacy Study in Subjects With Diabetic Neuropathic Pain

Assessment of Dual AntiPlatelet Therapy With Drug Eluting Stents

Variability of Ventricular Mass, Volume, & Ejection Fraction in Pediatric Cardiomyopathy Patients-Pediatric Heart Network

Efficacy and Safety Study for Subjects With Mild-to-Moderate Alzheimer's Disease

Multicenter Worksite Nutrition Study